A 56-year-old man with liver failure has become the first living person to be surgically connected to a genetically modified ...

In this installment in our series about diseases preventable by vaccination, we examine hepatitis A and why protection from ...

Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...

The U.K. pharmaceutical company said it would receive $300 million upfront and be eligible to receive another $100 million upon approval for the drug in the U.S. and a further $290 million subject to ...

Odisha government is in talks with AIG Hospitals, Hyderabad, to establish a research centre for advanced health sciences. The ...

In Haryana's Palwal, deaths linked to energy drinks and unqualified doctors prompted FIRs against five practitioners, with a health emergency declared.

A year after Sen. Bill Cassidy warily cast the vote that ensured Robert F. Kennedy Jr.’s confirmation, the Louisiana ...

Orziloben granted Orphan Drug Designation in the U.S. and European Union Company expects to report topline results from Phase 2 study in Q3 2026 NorthSea Therapeutics B.V. ("NorthSea" or the "Company" ...

Discover how lifestyle risks are impacting cancer cases in Singapore and the multi-faceted approach needed for effective ...

New research from Masonic Medical Research Institute shows that fatty liver disease alone does not directly cause heart failure with preserved ejection fraction.

Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...

Approval expands indication of JUXTAPID® to include children 2 years of age and older with HoFH. This announcement was made ...